Association between warfarin and COVID-19-related outcomes compared with direct oral anticoagulants: population-based cohort study

BACKGROUND: Thromboembolism has been reported as a consequence of severe COVID-19. Although warfarin is a commonly used anticoagulant, it acts by antagonising vitamin K, which is low in patients with severe COVID-19. To date, the clinical evidence on the impact of regular use of warfarin on COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Angel Y. S., Tomlinson, Laurie A., Brown, Jeremy P., Elson, William, Walker, Alex J., Schultze, Anna, Morton, Caroline E., Evans, David, Inglesby, Peter, MacKenna, Brian, Bhaskaran, Krishnan, Rentsch, Christopher T., Powell, Emma, Williamson, Elizabeth, Croker, Richard, Bacon, Seb, Hulme, William, Bates, Chris, Curtis, Helen J., Mehrkar, Amir, Cockburn, Jonathan, McDonald, Helen I., Mathur, Rohini, Wing, Kevin, Forbes, Harriet, Eggo, Rosalind M., Evans, Stephen J. W., Smeeth, Liam, Goldacre, Ben, Douglas, Ian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525065/
https://www.ncbi.nlm.nih.gov/pubmed/34666811
http://dx.doi.org/10.1186/s13045-021-01185-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525065/
https://www.ncbi.nlm.nih.gov/pubmed/34666811
http://dx.doi.org/10.1186/s13045-021-01185-0

Ejemplares similares